21,120,000 (Twenty-One Million One Hundred and Twenty Thousand Baht Only), for utilization in construction of an additional office building and parking space to accommodate an increase in number of staff at

more cash flow circulate in its operation. Board of Directors’ Opinion. Agreed to approve the sale in order to increase liquidity of the Company and also decrease debt and interest expenses Please be

’ Opinion. Agreed to approve the sale in order to increase liquidity of the Company and also decrease debt and interest expenses Please be informed accordingly. Sincerely Yours, (Mr. Yuttana Taepangthong

Financial Status. Current Ratio is 9.42 times and Debt to Equity Ratio equals 0.11 times due to the proceeds of 164 M.Bht from registered capital increase in January 2017, and from sales unused land amounting

medical treatments when compared to income from medical treatments went up 1.94% from CMR a subsidiary went up 3.73% due to expending employment increase and depreciation of building is increasing. The cost

and its subsidiaries have contract revenues for Q1/2019 amount 220 Million Baht which is increase of 93 Million Baht (73%) from Q1/2018 contract revenues. Q1/2019’s net loss of 67 Million Baht

; Unimit and its subsidiaries have contract revenues for Q1/2019 amount 220 Million Baht which is increase of 93 Million Baht (73%) from Q1/2018 contract revenues. Q1/2019’s net loss of 67 Million Baht

% and the separate financial increase 10.55%. 3. The net income decreased 43.78% (Separate financial statement : increased 34.52 %) due to Social Security Office reimbursement from CMR of 2015 and 2016

totaling 0.81 million Baht or 22.69% due to long term loan repayments. Net profit (loss) The company recorded net loss of 14.05 million Baht in the first quarter of 2019, an increase of 13.01 million Baht

in selling price from 4th quarter of 2019 affect revenue from sales slightly increase in comparison to increasing in sales quantities. Other income increased 35.00% from the same period of last year